Incidence of Refeeding Syndrome in Consecutively Admitted Patients
NCT ID: NCT05967858
Last Updated: 2023-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
51 participants
OBSERVATIONAL
2013-12-01
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Refeeding to Optimize iNpatient Gains
NCT02488109
Hunger and Satiety in Anorexia Nervosa
NCT02932046
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
NCT05197309
Anorexia Nervosa and Its Effects on Brain Function, Body Metabolism and Their Interaction
NCT05101538
Re-nutrition in Severe Anorexia Nervosa
NCT02502617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During hospitalization patients were monitored with daily blood samples and clinical evaluation of symptoms in addition to the coverage of energy and protein in percent of estimated needs.
Refeeding phenomenon was defined as a decrease in plasma phosphate after the initiation of nutrition.
Refeeding syndrome as refeeding phenomenon and one or more relevant symptoms in addition (hypotension, cardiac arrhythmia, edema, confusion)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
gastroenterological
Consecutive admissions - n= 43 - 34 operated (79%) - 10 patients acutely admitted Diseases in Esophagus (8), gastric cavity (8), pancreas (7), colon/rectum (8), bile (4), small intestine (3), IBD (5) No interventions in the treatments, just observation
observation
no intervention
head and neck cancer
Consecutive admissions - n=8 - 7 radiation therapy - 1 operated Locations: 2 Larynx, 1 oro-pharynx, 4 tonsillar, 1 tung No interventions in the treatments, just observation
observation
no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observation
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years
* written consent
Exclusion Criteria
* Lack of ability to communicate (registration of nutritional intake etc)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Olavs Hospital
OTHER
Jens Rikardt Andersen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jens Rikardt Andersen
Assoc Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jens R Andersen, MD, MPA
Role: STUDY_CHAIR
University of Copenhagen
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
norge refeed
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.